Prevalensi Wuchereria bancrofti Paska Pemberian Obat Pencegahan Massal Filariasis Limfatik di Wilayah Endemis Rendah Kota Pekalongan

  • Mara Ipa Loka Penelitian dan Pengembangan Kesehatan Pangandaran,Jalan Raya Pangandaran Km 3, Pangandaran, Indonesia https://orcid.org/0000-0002-4831-6536
  • Eksi Wijayanti Subdit Filariasis dan Kecacingan Direktorat Pencegahan dan Pengendalian Penyakit Tular Vektor dan Zoonotik, Jalan HR Rasuna Said, Jakarta Pusat, Indonesia
  • Hipokrates Hipokrates Subdit Filariasis dan Kecacingan Direktorat Pencegahan dan Pengendalian Penyakit Tular Vektor dan Zoonotik, Jalan HR Rasuna Said, Jakarta Pusat, Indonesia
  • Endang Puji Astuti Loka Penelitian dan Pengembangan Kesehatan Pangandaran,Jalan Raya Pangandaran Km 3, Pangandaran, Indonesia
  • Yuneu Yuliasih Loka Penelitian dan Pengembangan Kesehatan Pangandaran,Jalan Raya Pangandaran Km 3, Pangandaran, Indonesia
Keywords: lymphatic filariasis, mass drug administration, prevalence, Pekalongan

Abstract

Pekalongan district has completed mass drug administration (MDA) of lymphatic filariasis (LF) for two rounds but still remains positive for microfilariae (Mf rate) > 1%. This study aimed was to assess the prevalence of Wuchereria bancrofti and its association with sociodemographic among the adult community to the incidence of lymphatic filariasis. This study is an analytic study with a cross-sectional design. The prevalence of W. bancrofti was detected by the presence of circulating filarial antigen (CFA) using a filarial test strip (FTS). The study population consisted of an adult group living in ten villages in the Pekalongan district's low-endemic region, with 1804 samples collected from 72 clusters. Statistical analysis was performed to test the difference between variables. There were 13 (0.72%) positive W. bancrofti antigen samples out of 1804 total samples. Males were found to be infected at a higher rate than females (61.5%). The age of subjects infected with W. bancrofti was dominated in the range of 13-50 years as many as 9 people (69.2%). The proportion of positive CFA in Medono village with the highest proportion was 6 people (2.7%). There was no statistically significant difference between gender and age with LF cases, but it is significantly different by sub-district (p-value = 0.041). LF transmission occurred in border areas between high and low endemic LF areas. MDA implementation must be constantly supervised in required to address the elimination target.

Author Biography

Mara Ipa, Loka Penelitian dan Pengembangan Kesehatan Pangandaran,Jalan Raya Pangandaran Km 3, Pangandaran, Indonesia

References

1. Kemenkes RI. Pedoman penentuan dan evaluasi daerah endemis filariasis. In: Pedoman eliminasi filariasis di Indonesia. Jakarta: Kemenkes RI; 2015. p1-47.

2. Mathew CG, Bettis AA, Chu BK, English M, Ottesen EA, Bradley MH, et al. The health and economic burden of lymphatic filariasis prior to mass drug administration programmes. Clin Infect Dis. 2020;70(12):2561-7. doi:10.1093/cid/ciz671.

3. World Health Organization (WHO). Lymphatic filariasis : key facts. WHO; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/lymphatic-filariasis.

4. World Health Organization (WHO). Global programme to eliminate lymphatic filariasis. WHO; 2020. [Cited 2021 May 19]. Available from: https://www.who.int/lymphatic_filariasis/elimination-programme/en/.

5. Chandrasena N, Premaratna R, Gunaratna IE, de Silva NR. Morbidity management and disability prevention for lymphatic filariasis in Sri Lanka: Current status and future prospects. PLoS Negl Trop Dis. 2018;12(5):e0006472. doi:10.1371/journal.pntd.0006472.

6. Direktorat Pencegahan dan Pengendalian Penyakit Tular Vektor dan Zoonotik. Strategi percepatan dan penanggulangan filariasis dan kecacingan di Indonesia. Dalam pertemuan koordinasi dalam rangka peningkatan monitoring dan evaluasi program penanggulangan filariasis dan kecacingan tanggal 11-14 Februari 2020 di Jakarta.

7. Ramadhan N, Yulidar Y, Nur A, Hadifah Z, Yasir Y. Gambaran status endemisitas filariasis dan faktor yang terkait dengan transmisi sesaat pasca survei Transmission Assessment Survey (TAS-) 1 di Kabupaten Pidie, Aceh. Media Penelit dan Pengemb Kesehat. 2019;29(4):353-64. doi:10.22435/mpk.v29i4.2099.

8. Ikawati B, Wijayanti T, Jastal. The threat of lymphatic filariasis elimination failure in Pasaman Barat District, West Sumatra Province. Indian J Public Heal Res Dev. 2018; 9(6):446–51.

9. Suryaningtyas NH, Arisanti M, Satriani AV, Inzana N, Santoso S, Suhardi S. Kondisi masyarakat pada masa surveilans pasca-Transmission Assessment Survey (TAS)-2 menuju eliminasi Filariasis di Kabupaten Bangka Barat, Bangka Belitung. Bul Penelit Kesehat. 2018; 46(1): 35–44. doi: https://doi.org/10.22435/bpk.v46i1.55.

10. Rahayu N, Suryatinah Y, Paisal P. Penemuan Mikrofilaria Brugia malayi di wilayah yang telah lulus Transmission Assesment Survey (TAS-3) di Kabupaten Kotawaringin Barat Provinsi Kalimantan Tengah. ASPIRATOR. 2019;1(2):73–80. doi: https://doi.org/10.22435/asp.v11i2.1318.

11. Santoso S, Cahyaningrum S. Re-transmission assessment survey filariasis pasca pengobatan massal di Kabupaten Agam, Provinsi Sumatera Barat Tahun 2016. BALABA. 2018;13(2):143–52. doi: 10.22435/blb.v13i2.263.

12. Shamsuzzaman AKM, Haq R, Karim MJ, Azad MB, Mahmood ASMS, Khair A, et al. The significant scale up and success of Transmission Assessment Surveys ‘TAS’ for endgame surveillance of lymphatic filariasis in Bangladesh: One step closer to the elimination goal of 2020. PLoS Negl Trop Dis. 2017;11(1):e0005340. doi:10.1371/journal.pntd.0005340.

13. Wahyudi BF, Pramestuti N. Kondisi filariasis pasca pengobatan massal di Kelurahan Pabean Kecamatan Pekalongan Utara Kota Pekalongan. BALABA. 2016;12(1):55-60. doi:10.22435/blb.v12i1.4635.55-60.

14. Widjanarko B, Saraswati LD, Ginandjar P. Perceived threat and benefit toward community compliance of filariasis’ mass drug administration in Pekalongan district, Indonesia. Risk Manag Healthc Policy. 2018; 11:189–97. doi: 10.2147/RMHP.S172860. eCollection 2018.

15. Burgert-Brucker CR, Zoerhoff KL, Headland M, Shoemaker EA, Stelmach R, Karim MJ, et al. Risk factors associated with failing pretransmission assessment surveys (Pre-tas) in lymphatic filariasis elimination programs: Results of a multi-country analysis. PLoS Negl Trop Dis. 2020;14(6):e0008301.

16. Biritwum NK, Frempong KK, Verver S, Odoom S, Alomatu B, Asiedu O, et al. Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities. PLoS Negl Trop Dis. 2019;13(8):e0007115. doi:10.1371/journal.pntd.0007115.

17. Ipa M, Astuti EP, Hakim L, Fuadzy H. Analisis cakupan obat massal pencegahan filariasis di Kabupaten Bandung dengan pendekatan model sistem dinamik. BALABA. 2016;12(1):31–8.

18. Schmaedick MA, Koppel AL, Pilotte N, Torres M, Williams SA, Dobson SL, et al. Molecular xenomonitoring using mosquitoes to map lymphatic filariasis after mass drug administration in American Samoa. PLoS Negl Trop Dis. 2014;8(8):e3087. doi:10.1371/journal.pntd.0003087.

19. Pi-Bansa S, Osei JHN, Kartey-Attipoe WD, Elhassan E, Agyemang D, Otoo S, et al. Assessing the presence of Wuchereria bancrofti infections in vectors using xenomonitoring in lymphatic filariasis endemic districts in Ghana. Trop Med Infect Dis. 2019;4(1):1–13. doi: 10.3390/tropicalmed4010049

20. Purnama W. Nurjazuli, Raharjo M. Faktor lingkungan dan perilaku masyarakat yang berhubungan dengan kejadian filariasis di Kecamatan Muara Pawan Kabupaten Ketapang Provinsi Kalimantan Barat. J Kesehat Lingkung Indones. 2017;16(1): 8-16.

21. Astuti EP, Ipa M, Wahono T, Ruliansyah A. Analisis perilaku masyarakat terhadap kepatuhan minum obat filariasis di tiga desa Kecamatan Majalaya Kabupaten Bandung Tahun 2013. Media Penelit dan Pengemb Kesehat. 2014;24(4):199-208. doi:10.22435/mpk.v24i4.3675.199-208.

22. Roy RN, Sarkar AP, Misra R, Chakroborty A, Mondal TK, Bag K. Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan district, West Bengal, India. J Heal Popul Nutr. 2013;31(2):171–7. doi: 10.3329/jhpn.v31i2.16380.

23. Pani SP, Balakrishnan N, Srividya A, Bundy DAP, Grenfell BT. Clinical epidemiology of bancroftian filariasis: Effect of age and gender. Trans R Soc Trop Med Hyg. 1991; 85(2):260–4.

24. Afra D, Harminarti N, Abdiana. Faktor-faktor yang berhubungan dengan kejadian filariasis di Kabupaten Padang Pariaman Tahun 2010-2013. J Kesehat Andalas. 2016;5(1):111-9

25. Irfan, Kambuno NT, Israfil. Factors affecting the incidence of filariasis in Welamosa Village Ende District East Nusa Tenggara. Glob Med Heal Commun. 2018;6(2):130–7.

26. Onggang FS. Analisis faktor faktor terhadap kejadian filariasis type Wuchereria Bancrofti, dan Brugia Malayi di wilayah Kabupaten Manggarai Timur Tahun 2016. J Info Kesehat. 2018;16(1). doi: 10.31965/infokes.Vol16.Iss1.165.

27. Sularno S, Nurjazuli N, Raharjo M. Faktor- faktor yang berhubungan dengan kejadian Filariasis di Kecamatan Buaran Kabupaten Pekalongan. J Kesehat Lingkung Indones. 2017;16(1):22-8. doi: 10.14710/jkli.16.1.22-28.

28. Harfaina H, Hadisaputro S, Lukmono DT, Sakundarno M. Faktor-faktor yang mempengaruhi ketidakpatuhan minum obat sebagai upaya pencegahan filariasis di Kota Pekalongan. J Ilm Permas J Ilm STIKES Kendal. 2019;9(1): 1–6. doi: 10.32583/pskm.9.1.2019.1-6

29. Krentel A, Fischer PU, Weil GJ. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. 2013;7(11):e2447. doi:10.1371/journal.pntd.0002447.

30. Nurjazuli. Entomology survey based on lymphatic filariasis locus in the District of Pekalongan City Indonesia. Int J Sci Basic Appl Res. 2015;22: 295–302.

31. Ramadhani T, Wahyudi BF. Kenekaragaman dan dominasi nyamuk di daerah endemis filariasis limfatik, Kota Pekalongan. J Vektor Penyakit. 2015;9(1):1–8.

32. Lau CL, Won KY, Lammie PJ, Graves PM. Lymphatic filariasis elimination in american samoa: Evaluation of molecular xenomonitoring as a surveillance tool in the endgame. PLoS Negl Trop Dis. 2016;10(11):e0005108. doi:10.1371/journal.pntd.0005108.

33. Bah YM, Paye J, Bah MS, Conteh A, Redwood-Sawyerr V, Sonnie M, et al. Achievements and challenges of lymphatic filariasis elimination in Sierra Leone. PLoS Negl Trop Dis. 2020;14(12): e0008877. doi: 10.1371/journal.pntd.0008877

34. Irvine MA, Stolk WA, Smith ME, Subramanian S, Singh BK, Weil GJ, et al. Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study. Lancet Infect Dis. 2017;17(4): 451–8.

35. King CL, Weil GJ, Kazura JW. Single-dose triple-drug therapy for Wuchereria bancrofti — 5-Year Follow-up . N Engl J Med. 2020; 382(20): 1956–7. doi: 10.1056/NEJMc1914262.
Published
2021-12-09
How to Cite
1.
Ipa M, Wijayanti E, Hipokrates H, Astuti E, Yuliasih Y. Prevalensi Wuchereria bancrofti Paska Pemberian Obat Pencegahan Massal Filariasis Limfatik di Wilayah Endemis Rendah Kota Pekalongan. blb [Internet]. 9Dec.2021 [cited 19May2022];17(2):143-52. Available from: https://ejournal2.litbang.kemkes.go.id/index.php/blb/article/view/4854
Section
Articles